Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection

Microbes and Infection

Volumn 6, Issue 5, 2004, Pages 468-474

  Onishi, Kotaro ^a   Li, Yang ^a   Ishii, Kazunari ^a   Hisaeda, Hajime ^a   Tang, Lijun ^a   Duan, Xuefeng ^a   Dainichi, Teruki ^a   Maekawa, Yoichi ^b   Katunuma, Nobuhiko ^c   Himeno, Kunisuke ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Antigen processing; Antigen presenting cell; APC; Cathepsin B Leishmania major; Cathepsin L; Ii; Invariant chain; LN; Lymph node; Lysosomal proteases; Mitochondria and lysosome; ML; SLA; Soluble Leishmania antigen; Th1; Th2

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; LYSOSOME ENZYME; PARASITE ANTIGEN;

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; FEMALE; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, PROTOZOAN; CATHEPSIN B; CATHEPSINS; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; DIPEPTIDES; DISEASE MODELS, ANIMAL; EPOXY COMPOUNDS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; PROTEASE INHIBITORS; PYRIDINES; TH1 CELLS; TH2 CELLS;

LEISHMANIA MAJOR;

EID: 11144357881     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.01.008     Document Type: Article

References (29)

1. Reiner S.L., Wang Z.E., Hatam F., Scott P., Locksley R.M. TH1 and TH2 cell antigen receptors in experimental leishmaniasis. Science. 259:(5100):1993;1457-1460.
2. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:1995;151-177.
3. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., Locksley R.M. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:(1):1989;59-72.
4. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:1997;821-850.
5. Germain R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:(2):1994;287-299.
6. Mizuochi T., Yee S.T., Kasai M., Kakiuchi T., Muno D., Kominami E. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain. Immunol. Lett. 43:(3):1994;189-193.
7. + T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. J. Immunol. 161:(5):1998;2120-2127.
8. Zhang T., Maekawa Y., Hanba J., Dainichi T., Nashed B.F., Hisaeda H., et al. Lysosomal cathepsin B plays an important role in antigen processing, while cathepsin D is involved in degradation of the invariant chain in ovalbumin-immunized mice. Immunology. 100:(1):2000;3-20.
9. Zhang T., Maekawa Y., Yasutomo K., Ishikawa H., Fawzy Nashed B., Dainichi T., et al. Pepstatin A-sensitive aspartic proteases in lysosome are involved in degradation of the invariant chain and antigen-processing in antigen-presenting cells of mice infected with Leishmania major. Biochem. Biophys. Res. Commun. 276:(2):2000;693-701.
10. Nakagawa T., Roth W., Wong P., Nelson A., Farr A., Deussing J., et al. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science. 280:(5362):1998;450-453.
11. + T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. J. Exp. Med. 195:(10):2002;1349-1358.
12. Cresswell P. Proteases, processing, and thymic selection. Science. 280:(5362):1998;394-395.
13. Riese R.J., Wolf P.R., Bromme D., Natkin L.R., Villadangos J.A., Ploegh H.L., Chapman H.A. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity. 4:(4):1996;357-366.
14. Hsieh C.S., deRoos P., Honey K., Beers C., Rudensky A.Y. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation. J. Immunol. 168:(6):2002;2618-2625.
15. Villadangos J.A., Bryant R.A., Deussing J., Driessen C., Lennon-Dumenil A.M., Riese R.J., et al. Proteases involved in MHC class II antigen presentation. Immunol. Rev. 172:1999;109-120.
16. Nakagawa T.Y., Rudensky A.Y. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Immunol. Rev. 172:1999;121-129.
17. Ishidoh K., Takeda-Ezaki M., Watanabe S., Sato N., Aihara M., Imagawa K., et al. Analysis of where and which types of proteinases participate in lysosomal proteinase processing using bafilomycin A1 and Helicobacter pylori Vac A toxin. J. Biochem. (Tokyo). 125:(4):1999;770-779.
18. Zhang T., Maekawa Y., Sakai T., Nakano Y., Ishii K., Hisaeda H., et al. Splenic cathepsin L is maturated from the proform by interferon-gamma after immunization with exogenous antigens. Biochem. Biophys. Res. Commun. 283:(2):2001;499-506.
19. Katunuma N., Murata E., Kakegawa H., Matsui A., Tsuzuki H., Tsuge H., et al. Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo. FEBS Lett. 458:(1):1999;6-10.
20. Tianqian Z., Yoichi M., Tohru S., Yoko N., Kazunari I., Hajime H., et al. Treatment with cathepsin L inhibitor potentiates Th2-type immune response in Leishmania major - infected BALB/c mice. Int. Immunol. 13:(8):2001;975-982.
21. Murata M., Miyashita S., Yokoo C., Tamai M., Hanada K., Hatayama K., et al. Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro. FEBS Lett. 280:(2):1991;307-310.
22. Towatari T., Nikawa T., Murata M., Yokoo C., Tamai M., Hanada K., et al. Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo. FEBS Lett. 280:(2):1991;311-315.
23. Barrett A.J., Kirschke H. Cathepsin B, Cathepsin H, and Cathepsin L. Methods in Enzymol. vol. 80:1981;535-561 Elsevier, San Diego.
24. Werle B., Staib A., Julke B., Ebert W., Zladoidsky P., Sekirnik A., et al. Fluorometric microassays for the determination of cathepsin L and cathepsin S activities in tissue extracts. Biol. Chem. 380:(9):1999;1109-1116.
25. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:1997;297-322.
26. + T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 182:(5):1995;1579-1584.
27. Pamer E.G. Antigen presentation in the immune response to infectious diseases. Clin. Infect. Dis. 28:(4):1999;714-716.
28. Honey K., Benlagha K., Beers C., Forbush K., Teyton L., Kleijmeer M.J., et al. Thymocyte expression of cathepsin L is essential for NKT cell development. Nat. Immunol. 3:(11):2002;1069-1074.
29. Brown D.R., Fowell D.J., Corry D.B., Wynn T.A., Moskowitz N.H., Cheever A.W., Locksley R.M., Reiner S.L. Beta 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J. Exp. Med. 184:(4):1996;1295-1304.